Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.
  • Abstract must be in Bahasa and English

Author Guidelines

Conditions for Submission

  • Articles are accepted for exclusive publication in The Journal of Indonesian Orthopaedic & Traumatology. Previous presentation at a scientific meeting, and/or publication of the abstract in conjunction with the meeting, does not preclude publication of the article; however, this information must be disclosed in a cover letter at the time of submission. Previously published articles, including those published in non-English-language journals, are not accepted.
  • Physical and electronic copies of published articles and illustrations become the property of The Journal of Indonesian Orthopaedic & Traumatology.
  • All clinical trials (i.e., any clinical study in which patients are randomized into two treatment groups OR are followed prospectively to compare two different treatments) must have been registered in a public trials registry such as clinicaltrials.govin accordance with the International Committee of Medical Journal Editors (ICMJE) guidelines for trial registration.
  • All manuscripts dealing with the study of human subjects must include a statement that the subjects gave informed consent to participate and that the study was approved by an institutional review board or a similar committee. All studies should be carried out in accordance with the World Medical Association Declaration of Helsinki. Patient confidentiality must be protected.
  • All manuscripts reporting on experiments on animals must include a statement that the study has been approved by an animal utilization study committee. Information about the management of postoperative pain should be included.
  • If requested by the Editor-in-Chief, authors must make the tabulated raw data that forms the basis of their work available for examination in a timely fashion.

Submission Overview

Authors should, in general, follow the ICMJE's "Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals."

The following items must be submitted:

  1. Blinded Manuscript Text:See Manuscript Structure below.
  2. Complete Manuscript Text including (1) article title, (2) authors' names, in order in which they should appear, and academic degrees, (3) institution(s) at which the work was performed, (4) institution (and city and state or country) with which each author is affiliated, (5) corresponding author and his/her e-mail address (6) blinded manuscript text and (7) chart and figures, in a single Microsoft Word file (.doc or .docx).
  3. Copyright Transfer and Author Agreement: All authors must sign a Copyright Transfer and Author Agreement granting JOTI exclusive copyright to all material.
  4. Disclosure of Potential Conflicts of Interest:Authors must complete an ICMJE Conflict of Interest Statement form for each submitted manuscript. Scanned copies of the completed form are not acceptable. The ICMJE forms have no bearing on the decision to accept a manuscript.
  5. IRB Approval:A copy of the letter granting approval from the institutional review board or the animal utilization study committee is required. A translated version must be provided if the original approval is not written in English or Indonesian.

Manuscript Structure

All manuscripts must conform to the following formatting instructions:

  • File format:Microsoft Word 
  • Language: English
  • Line spacing:Double-spaced
  • Font: Times New Roman (size 12)
  • Page layout: Manuscript title included at the beginning of the first page with continuous line numbering down left side of page
  • Article format: should include all the following items
  1. Title: Complete title of the article without any abbreviations
  2. Structured abstract: consisting of 5 paragraphs, totaling no more than 250 words, with the headings: Background (stating the primary research question), Methods, Results, Conclusions, and Level of Evidence (for Clinical Research articles) or Clinical Relevance (for Basic-Science Research articles). The Level of Evidence should be assigned according to the definitions in the Level of Evidence table.
  3. Article body: The text should follow order of IMRAD (Introduction, Methods, Results, Discussion and Conclusions). System internationale units (S.I. Unit) must be used when stating meassurements. All meassurements should use metric system. Do not use unstandardized abbreviation. Do not commence sentence with numerical figure. Any numbers should be spelled out in form of words if they become the heading of the sentence.
  4. References: in Vancouver format, must be included after the manuscript text. Number the references according to the order of citation in the text (not alphabetically), and cite all references in the text. Papers posted on preprint servers may not be used as references.
  5. Figure legends must be included at the end of the manuscript text file, after the References section, for all images. Explain what each figure shows. Identify machine settings for magnetic resonance images, and give the magnification of all photomicrographs. Define all arrows and other such indicators appearing on the figure.
  6. Tables should be submitted a descriptive title above the table itself (do not include this information on the figure legends page). All tables should be cited in the manuscript text by table number.
  7. Figures must be submitted in TIFF, JPG or PNG format. No more than 10 separate image files may be submitted. Cite all figures, in order, in the text.

Article categories

  1. Original Research Articles: 
    Structure: Abstract, Introduction, Methods, Results, Discussion, and References 
    Abstract: Limited to 250 words, structured with the following headings: Background, Materials and Methods, Results, Conclusions 
    Total Word Limit: 3000 words 
    Reference Limit: 30 references 
  2. Review Article: 
    Structure: Reviews should provide a clear introducing and concluding sections. Sub-titles are at the author's discretion. 
    Abstract: Limited to 250 words, semi-structured (no titles or references) 
    Total Word Limit: 5000 words 
    Reference: Minimum 30 references, Maximum 50 references
  3. Case Reports: 
    Structure: Abstract, Introduction, Presentation of Case, Discussion, Conclusion, Consent of Patient 
    Abstract: Limited to 250 words, semi-structured (no titles or references) 
    Total Word Limit: 2000 words 
    Reference Limit: 15 references, Figure/Table Limit: 5 color figures or tables
  4. Editorial: 
    Structure: Editorials should provide a clear introducing and concluding sections. Sub-titles are at the author's discretion. 
    Abstract: Limited to 250 words, semi-structured (no titles or references) 
    Total Word Limit: 2,000 words 
    Reference Limit: 20 references, Figure/Table Limit: 3 color figures or tables
  5. Letter to Editor/ Commentary: 
    Structure: One body of text with no sub-titles 
    Abstract: None 
    Total Word Limit: 1,000 words 
    Reference Limit: 20 references, Figure/Table Limit: 3 color figures or tables
  6. Conference Proceeding: This type  of publication included abstracts from a registered conference which will be published as “Supplement” of the Journal.

Authorship

  • There is a general limit of six (6)
  • Each author must have contributed significantly to, and be willing to take public responsibility for, one or more aspects of the study: its design, data acquisition, and analysis and interpretation of data. All authors must have been actively involved in the drafting and critical revision of the manuscript, and each must provide final approval of the version to be published. Please refer to Uniform Requirement for Manuscripts submitted to Biomedical Journals: Writing and Editing for Biomedical Publication, updated April 2010 section IIA.

Articles

Section default policy

Copyright Notice

Download here for JOTI's Copyright and Transfer Author Agreement 

AUTHORS: PLEASE READ CAREFULLY - DO NOT BE GUILTY OF FRAUD OR DUPLICATE SUBMISSION OR PUBLICATION – CONTACT THE EDITORIAL OFFICE BEFORE SIGNING IF YOU HAVE ANY QUESTIONS!

  1. a. Each of the Author(s) hereby transfers, assigns and otherwise conveys to JOTI Editorial,. all right, title and interest in the Work (excluding videos), including but not limited to any and all copyright(s) therein held by each undersigned Author, together with any rights of each such Author to secure renewals, reissues and extensions of such copyright that may be secured under the laws now or hereafter in force and effect in the Indonesia or in any other country, and any and all rights to bring any court or other action to obtain damages, or injunctive or other relief, in connection with any past, present or future infringement of such copyright(s) or other claim in connection therewith.
  2. NOTE: If the article is accepted, the Author(s) shall have the right to elect to have it published according to the open-access model, which provides the public with free unrestricted online access to the article on the corresponding journal’s web site immediately upon publication. If the Author(s) choose the open-access option and pay the applicable article processing charge, the Author(s) will retain the copyright to the article by signing, and uploading to the manuscript submission system, the Open Access License Agreement (the “Open Access License”). The Open Access License grants JOTI Editorial. and its publishing partner the exclusive license to publish the article and to identify themselves as the original publisher. The Open Access License supersedes and replaces Section 1.a of this Agreement and the article is published under the terms of the Creative Commons license designated in the Open Access License.
  3. Each of the Author(s) hereby also grants permission to JOTI Editorial to use such Author’s name and likeness in connection with any past, present or future promotional activity by JOTI., including, but not limited to, promotions for upcoming issues or publications, circulation solicitations, advertising or other publications in connection with JOTI Editorial.
  4. Each of the Author(s) hereby warrants, represents and covenants that (i) each of the Author(s) has read and approved the final manuscript or version of the Work; (ii) the Work is original; (iii) the Author(s) are the sole owners of all rights of any kind in the Work; (iv) the Work has not been previously published and is not under consideration for publication by any person or entity, including electronic publishers, other than JOTI, and that the Author(s) have not previously transferred, assigned or conveyed, or agreed to transfer, assign or convey, any rights in connection with the Work to any person or entity other than JOTI; (v) the Work is not libelous, and the publication of the Work will not infringe upon or misappropriate any copyright, right to privacy, trade secret, proprietary or any other right of any person or other entity; and (vi) any and all necessary approvals, consents, waivers or permissions from third parties in connection with the Work and its publication have been obtained, and that the Author(s) will deliver copies of the same to JOTI. upon its request. Upon the request of the Editor-in-Chief of JOTI, the author(s) will provide to JOTI., in a timely fashion, any or all of the data, facts and information included in or forming the basis for the Work (the “Data”); JOTI. shall have the right to use (and to permit others to use) the Data in reviewing and/or editing the Work and for any other purpose other than the creation or publication of any other work based exclusively on the Data.
  5. To enable Author(s) to comply with the requirements of outside funding bodies, JOTI. will deposit, into the PubMed Central (PMC) Archive, the final published version of any article identified as requiring such deposit below. PMC will make these articles freely available after an embargo period of 12 months, 6 months (Wellcome Trust only), or immediately upon publication (if the Author(s) choose the open-access option).

Please disclose below if you have received funding for research on which your article is based from any of the following organizations. JOTI. will not be held responsible for retroactive deposits to PMC if the Author(s) do not identify the funding agency below.

 National Institutes of Health (NIH)  Wellcome Trust
 Howard Hughes Medical Institute (HHMI)  Research Councils UK (RCUK)
 Other funding body requiring deposit in repository offering free access after embargo (please list):

  1. Each of the Author(s) hereby releases and shall indemnify and hold harmless JOTI. and its successors, assigns, licensees, officers, directors, employees, and their respective heirs and representatives from and against any and all liabilities, losses, damages and expenses arising out of any claims of any kind that may be asserted against any of them based in whole or in part on any breach of the Author(s)’ representations or warranties herein or in the Work or anything contained in the Work, including but not limited to any claims for copyright infringement or violation of any rights of privacy or publicity.
  2. Nothing in this Agreement shall constitute any promise by or obligation of JOTI. to publish the Work, or any portions thereof, at any time in any publication. However, if at any time JOTI. finally elects not to publish the Work, JOTI. shall reconvey to the Author(s), without any representation, warranty or recourse, all of JOTI.’s rights in the Work under Section 1 hereof at the time of such reconveyance and shall notify the Author(s) of such election and reconveyance; the provisions of section 3 hereof shall survive such reconveyance, and in no event shall JOTI. have any obligation to return to any Author the manuscript or any other copy(ies) or embodiment(s) of the Work or the Data delivered to JOTI. by the Author(s) or made by JOTI.
  3. This Copyright Transfer and Author Agreement shall be governed by Indonesian law. In the unlikely event that the parties hereto are unable amicably to resolve any dispute arising under or in connection with this Agreement, such dispute shall be adjudicated in an appropriate court in Jakarta, Indonesia.

Upload and completed form to the online submission site or email a scanned copy to

journal_indonesianorthopaedic@yahoo.com

NOTE: Handwritten, DocuSigned, digitally verified Adobe, or similar signatures only. Digital signatures must display certification if printed. No other form of electronic or stamped signature is acceptable.

Authors are permitted to sign separate forms as long as each form is completed in its entirety.

 

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.